Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic beta cell hyperplasia in the mouse

Diabetologia

Volumn 48, Issue 6, 2005, Pages 1059-1065

  Poirier, H ^a   Rouault, C ^b   Clement L ^a   Niot, I ^a   Monnot, M C ^a   Guerre Millo, M ^c   Besnard, P ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔTEL DIEU   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Adipokines; Conjugated linoleic acid; Hepatic steatosis; Insulin resistance; Insulin secretion; Pancreatic beta cells

Indexed keywords

ADIPONECTIN; CARBACHOL; LEPTIN; LINOLEIC ACID; LIPID;

ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; FEEDING; FEMALE; HOMEOSTASIS; HYPERINSULINEMIA; INCUBATION TIME; INSULIN RELEASE; ISOMER; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID STORAGE; LIVER WEIGHT; MEASUREMENT; MORPHOMETRICS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PARAMETER; PRIORITY JOURNAL;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; HYPERINSULINISM; HYPERPLASIA; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; LEPTIN; LINOLEIC ACIDS, CONJUGATED; LIVER; MICE; MICE, INBRED C57BL; ORGAN SIZE; TRIGLYCERIDES;

EID: 21344469235     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1765-8     Document Type: Article

References (31)

1. Wang YW, Jones PJ (2004) Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes Relat Metab Disord 28: 941-955
2. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K et al (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49:1534-1542
3. Clément L, Poirier H, Niot I et al (2002) Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43:1400-1409
4. Malpuech-Brugere C, Verboeket-van de Venne WP, Mensink RP et al (2004) Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 12:591-598
5. Terpstra AH, Javadi M, Beynen AC et al (2003) Dietary conjugated linoleic acids as free fatty acids and triacylglycerols similarly affect body composition and energy balance in mice. J Nutr 133:3181-3186
6. Larsen TM, Toubro S, Astrup A (2003) Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 44:2234-2241
7. Riserus U, Arner P, Brismar K et al (2002) Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25:1516-1521
8. Shimomura I, Matsuda M, Hammer RE et al (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77-86
9. Shimomura I, Hammer RE, Richardson JA et al (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:3182-3194
10. Burant CF, Sreenan S, Hirano K et al (1997) Troglitazone action is independent of adipose tissue. J Clin Invest 100:2900-2908
11. Moitra J, Mason MM, Olive M et al (1998) Life without white fat: a transgenic mouse. Genes Dev 12:3168-3181
12. Gavrilova O, Marcus-Samuels B, Graham D et al (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271-278
13. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 7:941-946
14. Shimomura I, Hammer RE, Ikemoto S et al (1999) Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73-76
15. Poitout V, Rouault C, Guerre-Millo M et al (1998) Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology 139:822-826
16. Briaud I, Harmon JS, Kelpe CL et al (2001) Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50:315-321
17. Delsal JL (1944) Nouveau procédé d'extraction des lipides du sérum par le méthylal. Application aux microdosages du cholestérol total, des phospholipides et des protéines [Article in French]. Bull Soc Chim Biol (Paris) 26:99-105
18. Degrace P, Demizieux L, Gresti J, Chardigny JM, Sebedio JL, Clouet P (2004) Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10, cis-12-isomer of linoleic acid. J Nutr 134:861-867
19. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782
20. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084-1089
21. Fasshauer M, Kralisch S, Klier M et al (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301:1045-1050
22. Iwaki M, Matsuda M, Maeda N et al (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52:1655-1663
23. Peters JM, Park Y, Gonzalez FJ, Pariza MW (2001) Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice. Biochim Biophys Acta 1533:233-242
24. Yamauchi T, Kamon J, Minokoshi Y et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
25. Brown JM, Boysen MS, Jensen SS et al (2003) Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. J Lipid Res 44:1287-1300
26. Brown JM, Boysen MS, Chung S et al (2004) Conjugated linoleic acid (CLA) induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines. J Biol Chem 279:26735-26747
27. Rosen ED, Kulkarni RN, Sarraf P et al (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol 23:7222-7229
28. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB (1999) Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol 276:R1172-R1179
29. Bonner-Weir S (2000) Islet growth and development in the adult. J Mol Endocrinol 24:297-302
30. Medina EA, Horn WF, Keim NL et al (2000) Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 35:783-788
31. Riserus U, Vessby B, Arner P, Zethelius B (2004) Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47:1016-1019